ANI Pharmaceuticals, Inc. ANIP NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

70/100

3/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for ANI Pharmaceuticals, Inc. (ANIP), including 9 buys and 41 sells. Total insider buying was valued at $14.28M and total insider selling at $10.77M.

Notable insiders with recent activity include Mutz Christopher, Cook Meredith, Rowland Thomas Andrew. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — ANIP

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2026-03-13	Mutz Christopher	Head of Rare Disease	Informative Sell	3,162	$71.64	$226.53K	91,309
2026-03-13	Cook Meredith	Sr. VP, General Counsel & Sec.	Informative Sell	500	$72.62	$36.31K	79,390
2026-03-11	Rowland Thomas Andrew	SVP, Head - Established Brands	Informative Sell	4,772	$74.91	$357.47K	38,730
2026-03-09	Mutz Christopher	Head of Rare Disease	Informative Sell	3,602	$74.18	$267.2K	94,471
2026-03-09	Davis Krista	SVP, Chief HR Officer	Informative Sell	5,087	$74.13	$377.1K	51,946
2026-03-07	Carey Stephen P.	SVP & CFO	Tax Withholding of RSU	5,150	$74.04	$381.31K	180,393
2026-03-07	Lalwani Nikhil	President & CEO	Tax Withholding of RSU	17,060	$74.04	$1.26M	404,889
2026-03-07	Gutwerg Ori	SVP, Generics	Tax Withholding of RSU	3,314	$74.04	$245.37K	81,468
2026-03-07	Mutz Christopher	Head of Rare Disease	Tax Withholding of RSU	3,314	$74.04	$245.37K	98,073
2026-03-06	Mutz Christopher	Head of Rare Disease	Informative Sell	2,121	$74.22	$157.42K	101,387
2026-03-06	Davis Krista	SVP, Chief HR Officer	Informative Sell	1,485	$75.00	$111.38K	57,033
2026-03-05	Carey Stephen P.	SVP & CFO	Option Exercise (Sell)	3,312	$49.51	$163.98K	9,938
2026-03-03	Walsh Patrick D	Director	Informative Sell	6,000	$74.23	$445.38K	52,405
2026-03-03	Gutwerg Ori	SVP, Generics	Informative Sell	2,060	$76.50	$157.59K	84,782
2026-03-02	Mutz Christopher	Head of Rare Disease	Informative Sell	417	$74.00	$30.86K	103,508
2026-02-28	Rowland Thomas Andrew	SVP, Head - Established Brands	Tax Withholding of RSU	628	$73.90	$46.41K	43,502
2026-02-28	Carey Stephen P.	SVP & CFO	Tax Withholding of RSU	2,773	$73.90	$204.92K	189,543
2026-02-28	Lalwani Nikhil	President & CEO	Tax Withholding of RSU	12,217	$73.90	$902.84K	421,949
2026-02-28	Gutwerg Ori	SVP, Generics	Tax Withholding of RSU	2,221	$73.90	$164.13K	86,842
2026-02-28	Mutz Christopher	Head of Rare Disease	Tax Withholding of RSU	2,221	$73.90	$164.13K	103,925
2026-02-28	Gassert Chad	SVP - Corp. Dev. & Strategy	Tax Withholding of RSU	2,221	$73.90	$164.13K	74,916
2026-02-28	Cook Meredith	Sr. VP, General Counsel & Sec.	Tax Withholding of RSU	1,555	$73.90	$114.91K	79,890
2026-02-28	Davis Krista	SVP, Chief HR Officer	Tax Withholding of RSU	1,555	$73.90	$114.91K	58,518
2026-02-26	Rowland Thomas Andrew	SVP, Head - Established Brands	RSU Award	6,021	$77.15	$464.52K	44,130
2026-02-26	Carey Stephen P.	SVP & CFO	RSU Award	22,233	$77.15	$1.72M	192,316
2026-02-26	Lalwani Nikhil	President & CEO	RSU Award	75,592	$77.15	$5.83M	434,166
2026-02-26	Gutwerg Ori	SVP, Generics	RSU Award	12,969	$77.15	$1M	89,063
2026-02-26	Mutz Christopher	Head of Rare Disease	RSU Award	21,306	$77.15	$1.64M	106,146
2026-02-26	Shanmugam Muthusamy	Head of R&d, COO-novitium Ops	RSU Award	11,116	$77.15	$857.6K	101,056
2026-02-26	Gassert Chad	SVP - Corp. Dev. & Strategy	RSU Award	11,116	$77.15	$857.6K	77,137
2026-02-26	Cook Meredith	Sr. VP, General Counsel & Sec.	RSU Award	13,895	$77.15	$1.07M	81,445
2026-02-26	Davis Krista	SVP, Chief HR Officer	RSU Award	10,810	$77.15	$833.99K	60,073
2026-02-20	Mutz Christopher	Head of Rare Disease	Informative Sell	5,323	$78.02	$415.3K	84,840
2026-02-20	Davis Krista	SVP, Chief HR Officer	Informative Sell	1,730	$77.99	$134.92K	49,263
2026-02-19	Davis Krista	SVP, Chief HR Officer	Informative Sell	2,084	$77.53	$161.57K	50,993
2026-02-14	Rowland Thomas Andrew	SVP, Head - Established Brands	Tax Withholding of RSU	485	$77.36	$37.52K	38,109
2026-02-14	Carey Stephen P.	SVP & CFO	Tax Withholding of RSU	2,448	$77.36	$189.38K	170,083
2026-02-14	Lalwani Nikhil	President & CEO	Tax Withholding of RSU	10,298	$77.36	$796.65K	358,574
2026-02-14	Gutwerg Ori	SVP, Generics	Tax Withholding of RSU	1,888	$77.36	$146.06K	76,094
2026-02-14	Mutz Christopher	Head of Rare Disease	Tax Withholding of RSU	2,403	$77.36	$185.9K	90,163
2026-02-14	Gassert Chad	SVP - Corp. Dev. & Strategy	Tax Withholding of RSU	1,717	$77.36	$132.83K	66,021
2026-02-14	Cook Meredith	Sr. VP, General Counsel & Sec.	Tax Withholding of RSU	1,779	$77.36	$137.62K	67,550
2026-02-14	Davis Krista	SVP, Chief HR Officer	Tax Withholding of RSU	1,290	$77.36	$99.79K	53,077
2026-02-13	Cook Meredith	Sr. VP, General Counsel & Sec.	Informative Sell	500	$76.80	$38.4K	69,329
2026-02-12	Rowland Thomas Andrew	SVP, Head - Established Brands	Tax Withholding of RSU	566	$76.70	$43.41K	38,594
2026-02-12	Carey Stephen P.	SVP & CFO	Tax Withholding of RSU	2,829	$76.70	$216.98K	172,531
2026-02-12	Lalwani Nikhil	President & CEO	Tax Withholding of RSU	11,688	$76.70	$896.47K	368,872
2026-02-12	Gutwerg Ori	SVP, Generics	Tax Withholding of RSU	1,775	$76.70	$136.14K	77,982
2026-02-12	Mutz Christopher	Head of Rare Disease	Informative Sell	7,032	$76.55	$538.3K	92,566
2026-02-12	Gassert Chad	SVP - Corp. Dev. & Strategy	Tax Withholding of RSU	1,608	$76.70	$123.33K	67,738

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry